Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
267 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (18)
  • (-) Currently Recruiting (2)
  • Closed (16)

Medical Condition

  • Show all (267)
  • Addiction (4)
  • Allergy, Asthma, & Immunology (1)
  • Autoimmune Disorders (3)
  • Bone & Muscle (2)
  • Cancer (38)
  • COVID-19 (Coronavirus) (8)
  • Diabetes (6)
  • Ear, Nose and Throat (6)
  • Endocrine & Metabolic Disease (2)
  • Gastrointestinal and Digestive Diseases (5)
  • Hair and Skin Disorders (2)
  • Healthy Volunteers (46)
  • Heart Disease (20)
    • Cardiomyopathy (1)
    • (-) Heart Failure (1)
    • High Blood Pressure (3)
    • Peripheral Arterial Disease (1)
    • Valve Disease (5)
  • Infectious Disease (11)
  • Liver Disease (13)
  • Lung Disease (2)
  • Neurological Disorders (35)
  • Nutrition (1)
  • Obesity (9)
  • Obstetrics & Gynecology (11)
  • Pediatrics (19)
  • Psychiatric Disorders (7)
  • Rehabilitation (1)
  • Stroke (2)
  • Transplant (12)
    • (-) Kidney Transplant (1)
    • Liver Transplant (9)
  • Vascular Conditions (1)
Displaying 1 - 2 of 2

Drug interactions between Paxlovid and Tacrolimus in kidney transplant patients diagnosed with COVID-19

Condition: Transplant / Kidney Transplant
Investigator: Marcus Pereira, MD, MPH
Status: Currently Recruiting
This purpose of this study is to understand the interaction between two different medications, tacrolimus and Paxlovid (nirmatrelvir/ritonavir), in patients who have had a kidney transplant and are being treated by their doctor for COVID-19 infection. Tacrolimus is an oral medication that is used standardly in kidney transplant recipients to prevent…
Read More

The CORCINCH-HF Study: Study of AccuCinch in Patients with Symptomatic Heart Failure with Reduced Ejection Frraction (HFrEF)

Condition: Heart Disease / Heart Failure
Investigator: Gabriel Sayer, MD
Status: Currently Recruiting
This is a prospective, randomized, open-label, international, multi-center clinical study to evaluate the safety and efficacy of the AccuCinch Ventricular Repair System in patients with heart failure and reduced ejection fraction (HFrEF).
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science